FMP

FMP

Enter

XBIT - XBiotech Inc.

photo-url-https://images.financialmodelingprep.com/symbol/XBIT.png

XBiotech Inc.

XBIT

NASDAQ

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

6.4 USD

0.09 (1.41%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Mr. John Simard

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

CIK

0001626878

ISIN

CA98400H1029

CUSIP

98400H102

Address

5217 Winnebago Lane

Phone

512 386 2900

Country

US

Employee

82

IPO Date

Apr 15, 2015

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

XBIT Financial Summary

CIK

0001626878

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

98400H102

ISIN

CA98400H1029

Country

US

Price

6.4

Beta

1.41

Volume Avg.

48.76k

Market Cap

195.09M

Shares

-

52-Week

3.81-9.96

DCF

6.57

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-6.1

P/B

-

Website

https://www.xbiotech.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest XBIT News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep